Loading...
•
Dec 31, 2022
USANA Q4 2022 Earnings Report
USANA's Q4 2022 performance saw a decrease in net sales and diluted EPS compared to the prior-year period, but active customer counts stabilized in key markets and increased sequentially.
Key Takeaways
USANA Health Sciences reported a decrease in net sales to $228 million and diluted EPS to $0.66 for the fourth quarter of 2022, compared to $267 million and $1.03, respectively, in the prior-year period. Active customer counts stabilized in several key markets and increased 3% sequentially. The company is reiterating its fiscal year 2023 net sales and diluted EPS outlook.
Fourth quarter net sales were $228 million, a decrease from $267 million in the prior-year period.
Diluted EPS for the fourth quarter was $0.66, compared to $1.03 in Q4 2021.
Active Customer counts stabilized in several key markets and increased 3% sequentially.
Company reiterates fiscal year 2023 net sales and diluted EPS outlook of $850 million to $950 million and $2.35 to $3.30, respectively.
Revenue by Geographic Location
Forward Guidance
The Company is reiterating its net sales and earnings per share outlook for fiscal year 2023 provided on January 5, 2023, as follows: Consolidated Net Sales $850 - $950 million Diluted EPS $2.35 - $3.30
Positive Outlook
- Strategies focused on increasing Active Customers.
- Return to live sales meetings and events.
- New market expansion efforts.
- New incentive opportunities for salesforce.
- Pursuing additional acquisition opportunities.
Challenges Ahead
- Difficult to forecast market response in China due to COVID-19 policy changes.
- Active Customer base is 13% lower than the beginning of 2022.
- Focus on generating sequential quarter customer growth from current base.
- Experiencing increased costs due to inflationary pressures.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...